New From Kineticos

Press Release

January 20, 2025

Kincell Bio, a Kineticos Disruptor Fund II Company, Announces Mark Bamforth as CEO

Kincell Bio Welcomes Industry Veteran Mark R. Bamforth as Chief Executive Officer to Drive Business Growth   Research Triangle Park,…

Press Release

May 21, 2024

Kineticos Venture Partner Mark Bamforth Named Board Chairman of Kincell Bio

Kincell Bio Announces New Board Chairman Mark R. Bamforth to Accelerate Company’s Growth and Expansion May 21st 2024 – Kincell Bio,…

Press Release

April 4, 2024

Kineticos Invests in EnteroBiotix Funding Round, Initiates Phase 2 Study

EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials, Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowl…

Media Coverage

February 22, 2024

Kineticos Portfolio Company, neuro42, receives FDA Clearance

neuro42, a Kineticos Portfolio Company, Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging…

Press Release

January 23, 2024

Kineticos and INCATE join forces in supporting AMR innovators

 Kineticos and INCATE join forces in supporting AMR innovators December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in…